Cargando…
Immune checkpoint inhibitors in renal cell carcinoma
The immune system has long been known to play a critical role in the body’s defence against cancer, and there have been multiple attempts to harness it for therapeutic gain. Renal cancer was, historically, one of a small number of tumour types where immune manipulation had been shown to be effective...
Autores principales: | Ross, Kirsty, Jones, Rob J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Portland Press Ltd.
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5869245/ https://www.ncbi.nlm.nih.gov/pubmed/29079639 http://dx.doi.org/10.1042/CS20160894 |
Ejemplares similares
-
Combination VEGFR/immune checkpoint inhibitor therapy: a promising new treatment for renal cell carcinoma
por: Lee, Chung-Han, et al.
Publicado: (2018) -
Editorial: Immune checkpoint inhibitors in renal cell carcinoma
por: Tykodi, Scott S., et al.
Publicado: (2023) -
Biomarkers for Immune Checkpoint Inhibitors in Renal Cell Carcinoma
por: Martin, Spencer D., et al.
Publicado: (2023) -
Immune Checkpoint Inhibitors in the Pre-operative Setting and Impact on the Primary Renal Tumor
por: Gulati, Shuchi, et al.
Publicado: (2022) -
Editorial Comment to A case of sarcoidosis‐like reaction associated with immune checkpoint inhibitors in metastatic renal cell carcinoma
por: Kijima, Toshiki
Publicado: (2021)